-
公开(公告)号:US20130040919A1
公开(公告)日:2013-02-14
申请号:US13589422
申请日:2012-08-20
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: A61K31/235 , A61K31/621 , A61P29/00 , A61K31/24 , A61P9/00 , A61P9/04 , C07C207/04 , A61K31/22
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式I的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
公开(公告)号:US20110263674A1
公开(公告)日:2011-10-27
申请号:US13177036
申请日:2011-07-06
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: A61K31/235 , A61K31/216 , A61K31/245 , C07D207/33 , A61P9/00 , C07C317/32 , C07C225/22 , C07C69/78 , C07C69/612 , A61P9/04 , A61K31/40 , C07C69/734
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式I的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
公开(公告)号:US20100173970A1
公开(公告)日:2010-07-08
申请号:US12710778
申请日:2010-02-23
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: A61K31/40 , A61K31/216 , A61K31/24 , C07D207/335 , C07C69/76 , A61P9/00 , A61P9/04
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式I的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
公开(公告)号:US08980871B2
公开(公告)日:2015-03-17
申请号:US12678539
申请日:2008-09-19
CPC分类号: A61K31/58 , Y02A50/411
摘要: Provided herein are methods of treating hemolysis by administering an active compound in an amount sufficient to treat said hemolysis. It has been found that nitroxyl donors or similar compounds preferentially react with cell-free OxyHb, as compared to OxyHb encapsulated in a red blood cell, and reacts with MetHb to form iron-nitrosyl Hb or nitrite bound MetHb. It has also been found that such compounds reduce cell-free Hb and hemolysis. Active compounds are also contemplated for use in combination therapies, for example, in combination with the administration of red blood cells and/or an agent that promotes hematopoiesis, or in combination with the administration of a nitric oxide donor.
摘要翻译: 本文提供了通过施用足以治疗所述溶血的量的活性化合物来治疗溶血的方法。 已经发现,与包封在红细胞中的OxyHb相比,硝酰基供体或类似化合物优先与无细胞的OxyHb反应,并与MetHb反应形成亚硝酰基Hb或亚硝酸盐结合的MetHb。 还已经发现,这些化合物减少无细胞的Hb和溶血。 还考虑活性化合物用于组合疗法,例如与施用红细胞和/或促进造血作用的药剂组合,或与施用一氧化氮供体组合使用。
-
公开(公告)号:US08569536B2
公开(公告)日:2013-10-29
申请号:US13589422
申请日:2012-08-20
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: C07C69/76 , C07C207/00 , A61K31/235 , A61K31/04
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式I的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
公开(公告)号:US07989652B2
公开(公告)日:2011-08-02
申请号:US12710778
申请日:2010-02-23
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: C07C69/76 , C07C207/00 , A61K31/235 , A61K31/04
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式I的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
公开(公告)号:US4306621A
公开(公告)日:1981-12-22
申请号:US152716
申请日:1980-05-23
IPC分类号: E21B43/247 , E21B43/30 , E21B47/04
CPC分类号: E21B43/247 , E21B43/30
摘要: An in situ coal gasification process adapted for large scale commercial projects is provided. Techniques are provided to insure establishment of a gasification front over the full seam thickness as each successive injection well in the array is brought on line. This is accomplished by controlling the oxidant introduction in a prescribed manner during the early stages of injection after pneumatic communication between well pairs has been established. Also provided are techniques and standards for avoiding or controlling subsidence and for conducting gasification operations in free water laden seams and in coal seams subject to spontaneous combustion.
摘要翻译: 提供了适应大规模商业项目的原位煤气化过程。 提供技术以确保在整个接缝厚度上建立气化前沿,因为阵列中的每个连续注入井被排成线。 这是通过在建立井对之间的气动连通之后在注射的早期阶段以规定的方式控制氧化剂引入来实现的。 还提供了用于避免或控制沉降和在自由含水的接缝和经受自燃的煤层中进行气化操作的技术和标准。
-
18.
公开(公告)号:US20100239522A1
公开(公告)日:2010-09-23
申请号:US12711306
申请日:2010-02-24
IPC分类号: A61K38/20 , C07D471/04 , A61K31/4375 , A61K31/56 , A61K38/46 , A61K31/52 , A61K31/706 , A61K35/74 , A61K38/16 , A61K31/555 , A61K33/24 , A61K31/7068 , A61K38/12 , A61K31/704 , A61K38/21 , A61K39/395 , A61K31/675 , A61K36/31 , A61P35/00
CPC分类号: C07D471/14 , A61K31/44 , A61K31/475 , A61K41/00 , A61K45/06 , A61K2300/00
摘要: A method of treating cancer in a subject in need thereof comprises administering said subject reserpine, yohimbine, an analog thereof, or a pharmaceutically acceptable salt or prodrug thereof, in an amount effective to treat the cancer. Compounds and compositions useful for carrying out the method are also described.
摘要翻译: 在有需要的受试者中治疗癌症的方法包括以有效治疗癌症的量施用所述受试者利血平,育亨宾,其类似物或其药学上可接受的盐或前药。 还描述了用于实施该方法的化合物和组合物。
-
公开(公告)号:US07696373B2
公开(公告)日:2010-04-13
申请号:US12293374
申请日:2007-04-13
申请人: S. Bruce King
发明人: S. Bruce King
IPC分类号: C07C69/76 , C07C207/00 , A61K31/235 , A61K31/04
CPC分类号: C07C207/04 , C07C2601/14
摘要: Active compounds of Formula (I) are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.
摘要翻译: 描述了式(I)的活性化合物:其中:R 1和R 2各自独立地为C 1 -C 4烷基; 或R 1和R 2一起形成C 2 -C 7亚烷基链; Z是非甾体抗炎药(NSAID); 以及其药学上可接受的盐和前药,及其使用方法。
-
-
-
-
-
-
-
-